Eimeria tenella and Coccidiosis in Broilers: Anticoccidial Resistance Monitoring and Alternative Control

Introduction

Avian coccidiosis remains one of the most economically burdensome enteric diseases in commercial broiler production worldwide. The obligate intracellular protozoan parasite Eimeria tenella, which invades the caecal epithelium, is a major contributor to morbidity, mortality, and reduced feed conversion efficiency. Over decades, control has relied heavily on prophylactic in-feed anticoccidials, including ionophores and synthetic chemicals. Widespread resistance to these compounds has necessitated the development of robust monitoring strategies and alternative interventions. This article provides a detailed examination of E. tenella biology, modern molecular diagnostic tools for resistance surveillance, and emerging non-pharmacological control methods such as probiotics and vaccination. For a broader overview of species identification and vaccine strategies, readers are directed to the companion article Avian Coccidiosis: Eimeria Species Identification, Commercial Vaccines, and Anticoccidial Resistance in Broiler Flocks.

Biology and Pathogenesis of Eimeria tenella

Eimeria tenella belongs to the phylum Apicomplexa and exhibits a monoxenous life cycle confined to the chicken host. Sporulated oocysts are ingested, excyst in the gizzard and small intestine, and release sporozoites that invade caecal epithelial cells. Endogenous development proceeds through merogony (asexual multiplication) followed by gametogony and oocyst formation. The pre-patent period is approximately 7 days. Pathological sequelae include caecal haemorrhage, mucosal necrosis, and impaired nutrient absorption. Heavy infections result in clinical signs such as bloody droppings, depression, and sudden death. Subclinical infections decrease weight gain and increase feed conversion ratio, causing substantial economic loss.

The precise molecular mechanisms of invasion involve rhoptry and microneme secretion, actin-myosin motor-driven gliding motility, and formation of the parasitophorous vacuole. Host immune responses are primarily cell-mediated, with CD4+ and CD8+ T lymphocytes playing pivotal roles. A hallmark of E. tenella infection is the induction of strong protective immunity after primary exposure, a property exploited by live vaccination strategies.

Diagnostic Monitoring: The Role of ITS1 Quantitative PCR

Traditional diagnosis of coccidiosis relies on faecal oocyst counts (oocysts per gram of faeces) and lesion scoring. However, these methods lack species specificity and are insensitive for low-level infections. Quantitative PCR (qPCR) targeting the internal transcribed spacer 1 (ITS1) region of the ribosomal DNA has become the gold standard for species-specific quantification of Eimeria oocysts in broiler litter and faeces. The ITS1 region exhibits sufficient interspecies polymorphism to discriminate among the seven recognised Eimeria species that infect chickens, including E. tenella, E. acervulina, E. maxima, and others.

The analytical workflow begins with oocyst disruption using bead-beating or freeze-thaw cycles, followed by DNA extraction. Primers and hydrolysis probes specific to E. tenella ITS1 are designed to amplify a 100-200 bp fragment. Standard curves generated from serial dilutions of known oocyst numbers enable absolute quantification. The limit of detection typically reaches 10-50 oocysts per gram of sample. This approach has been validated extensively for monitoring anticoccidial resistance, as shifts in species composition or increases in oocyst counts under drug pressure indicate resistance emergence.

Quantitative PCR also allows pooled sampling, reducing cost and labor. For a parallel discussion of ITS1-based diagnostics in ruminant coccidiosis, see Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts.

Anticoccidial Resistance: Ionophores and Chemical Agents

Resistance to anticoccidials is a global phenomenon and a major challenge in broiler production. Resistance mechanisms differ between the two main classes: ionophores and synthetic chemicals.

Ionophore Resistance

Ionophores (monensin, salinomycin, narasin, lasalocid, maduramicin) are polyether antibiotics that disrupt transmembrane ion gradients in the parasite, leading to osmotic death. Resistance in E. tenella develops gradually through repeated exposure at sub-lethal concentrations. The molecular basis involves altered membrane lipid composition, reduced drug accumulation, and mutations in mitochondrial genes. Cross-resistance among ionophores is incomplete but common; monensin-resistant strains often show reduced sensitivity to salinomycin.

Monitoring ionophore resistance is performed through in vivo battery trials where birds are infected with field isolates and fed medicated feed. Oocyst production and lesion scores are compared to sensitive reference strains. The resistance index (RI) is calculated as the ratio of oocyst output in medicated versus unmedicated groups. An RI above 0.5 typically indicates resistance.

Chemical Anticoccidial Resistance

Synthetic chemicals (toltrazuril, diclazuril, clopidol, decoquinate, nicarbazin, amprolium) target specific metabolic pathways. For example, toltrazuril inhibits mitochondrial respiration, diclazuril disrupts nuclear division, and amprolium competes with thiamine. Resistance to these compounds can emerge rapidly, especially when used continuously. E. tenella isolates resistant to multiple chemical anticoccidials have been documented worldwide. Resistance mechanisms include target site mutations (e.g., in the cytochrome b gene for some quinolones) and enhanced drug efflux.

A summary of commonly used anticoccidials and their resistance profiles is provided in Table 1.

Table 1: Anticoccidial Agents, Mechanisms, and Resistance Status in Eimeria tenella

These data underscore the need for routine resistance monitoring using both phenotypic and genotypic approaches.

Alternative Control Strategies

Probiotic Interventions

Probiotics offer a promising alternative to reduce reliance on anticoccidials. The gut microbiota interacts with E. tenella at multiple levels: competitive exclusion, immunomodulation, and production of antiparasitic metabolites. Specific Lactobacillus and Bifidobacterium strains have been shown to reduce oocyst shedding and caecal lesions in broilers. The mechanisms include enhancement of mucosal IgA production, upregulation of anti-inflammatory cytokines (IL-10, TGF-beta), and stimulation of CD8+ T cell responses.

Spore-forming Bacillus species, particularly Bacillus subtilis, produce surfactin and other lipopeptides that directly disrupt sporozoite motility. In commercial broiler trials, B. subtilis supplementation decreased oocyst counts by up to 40% and improved weight gain compared to infected controls. The efficacy of probiotics is strain-dependent and requires optimisation of dose, delivery, and timing relative to infection.

The complex interplay between probiotics and the gut microbiome is also relevant to other enteric diseases. For a detailed exploration of microbiome-targeted interventions in necrotic enteritis, see Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies.

Live Oocyst Vaccination

Vaccination remains the most effective non-drug control measure. Commercial live vaccines contain attenuated or non-attenuated oocysts of multiple Eimeria species, including E. tenella. Attenuation via serial passage in chicken embryos or gamma irradiation reduces pathogenicity while retaining immunogenicity. Controlled low-level exposure induces protective immunity without clinical disease.

Vaccination strategies include:

• Hatchery spray vaccination: Day-old chicks are sprayed with a suspension of sporulated oocysts.
• In-feed or water administration: Oocysts are mixed into feed or drinking water during the first week.
• In ovo vaccination: Embryonated eggs receive a vaccine suspension at day 18 of incubation (emerging technology).

Immune protection develops over 10-14 days and requires a consistent cycling of oocysts in the litter. Vaccine efficacy can be compromised by concurrent antimicrobial use, particularly ionophores that kill the vaccine oocysts. Therefore, vaccine programs must be integrated with anticoccidial rotation or withdrawal.

Recombinant vaccines targeting immunodominant antigens such as Eimeria tenella microneme-2 (EtMIC2) and surface antigen SAG have been developed but have not yet achieved the broad protection of live vaccines in field conditions.

Other Alternatives

• Phytobiotics: Plant-derived compounds (saponins, essential oils, tannins) exhibit anticoccidial effects. Artemisia annua extracts, rich in artemisinin, reduce oocyst output. Saponins from Quillaja saponaria enhance immune responses when co-administered with vaccines.
• Enzymes: Exogenous enzymes (phytase, xylanase) improve nutrient digestibility and may indirectly reduce coccidial burden by altering intestinal environment.
• Organic acids and prebiotics: Short-chain fatty acids (butyrate, propionate) lower luminal pH and inhibit sporozoite invasion. Mannan-oligosaccharides and fructo-oligosaccharides stimulate beneficial microbiota.

Integrated Resistance Monitoring Workflow

A systematic approach to anticoccidial resistance monitoring is essential for program optimisation. The following Mermaid diagram illustrates a decision tree combining molecular diagnostics, phenotypic testing, and management adjustments.

flowchart TD
    A[Broiler flock with clinical suspicion or routine surveillance], > B[Collect pooled faecal/litter samples]
    B, > C[ITS1-qPCR for species-specific oocyst quantification]
    C, > D{Oocyst counts above threshold?}
    D, No, > E[Continue current anticoccidial program; periodic re-test]
    D, Yes, > F[Isolate E. tenella oocysts via salt flotation and sporulation]
    F, > G[Perform in vivo battery trial with reference and field isolates]
    G, > H{Resistance index > 0.5?}
    H, No, > I[Susceptible; continue drug, enhance biosecurity]
    H, Yes, > J{Resistance to multiple classes?}
    J, No, > K[Rotate to a different class; re-test after two cycles]
    J, Yes, > L[Implement alternative control: live vaccination + probiotic]
    L, > M[Monitor oocyst dynamics with ITS1-qPCR q 2 weeks]
    M, > N{Oocyst load decreasing?}
    N, Yes, > O[Maintain vaccine-probiotic program; adjust rotation]
    N, No, > P[Re-evaluate vaccine strain coverage; consider phytobiotic boost]

This workflow integrates diagnostic data with intervention decisions. Continuous monitoring allows early detection of resistance shifts before clinical outbreaks occur.

Conclusion

Eimeria tenella remains a persistent threat to broiler production. Anticoccidial resistance is inevitable under sustained drug pressure, necessitating active surveillance using molecular tools such as ITS1-qPCR. Alternative control measures, particularly live vaccination and probiotic supplementation, offer sustainable solutions but require careful integration with existing management practices. The future of coccidiosis control lies in a holistic, data-driven approach that combines diagnostic monitoring, strategic drug rotation, and non-pharmacological interventions. Continued research into host-parasite interactions and recombinant vaccine development will further refine these strategies.

References

1. Chapman HD. Coccidiosis in the chicken: a review of immunity and vaccination. World's Poultry Science Journal.
2. Williams RB. Epidemiological studies of coccidiosis in the domestic fowl. Parasitology.
3. McDougald LR, Fitz-Coy SH. Coccidiosis. In: Diseases of Poultry.
4. Shirley MW, Harvey DA. Eimeria tenella: genetic recombination and resistance to anticoccidial drugs. Research in Veterinary Science.
5. Long PL, Millard BJ. Eimeria: infection and immunity. In: Avian Immunology.
6. Jeffers TK. Eimeria tenella: incidence of resistance using the oocyst index. Avian Diseases.
7. Bafundo KW. Anticoccidial resistance in poultry: a review. Poultry Science.
8. Chapman HD. Sensitivity of field isolates of Eimeria to monensin. Avian Pathology.
9. Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Veterinary Quarterly.
10. Blake DP, Tomley FM. Securing poultry production from the ever-present challenges of coccidiosis. Trends in Parasitology.
11. Stotish RL, Wang CC. Mechanism of action of anticoccidials. Journal of Protozoology.
12. Ball SJ. The development of resistance to anticoccidial drugs. International Journal for Parasitology.
13. Smith AL et al. Toward a better understanding of T cell-mediated immunity to Eimeria. Avian Pathology.
14. Rose ME, Hesketh P. Immunity to coccidiosis: stages of the life cycle of Eimeria tenella. Parasitology.
15. Lillehoj HS, Trout JM. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clinical Microbiology Reviews.
16. Yun CH et al. Commensal microbiota and its role in host resistance to enteric pathogens. Poultry Science.
17. Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Review of Vaccines.
18. Lee KW et al. Impact of dietary Lactobacillus on Eimeria tenella infection in chickens. Poultry Science.
19. Hume ME et al. Effect of a direct-fed microbial on Eimeria acervulina infection. Journal of Applied Poultry Research.
20. Dariusz Z et al. Bacillus subtilis spores reduce oocyst shedding in broilers. Avian Diseases.
21. Sheoran N et al. Probiotic modulation of caecal microbiota during coccidiosis. Anaerobe.
22. Dalloul RA et al. Enhanced mucosal immunity against Eimeria acervulina by a probiotic. Veterinary Parasitology.
23. Williams RB. Anticoccidial vaccines for broiler chickens: pathways to success. Parasitology Today.
24. Shirley MW. The genome of Eimeria tenella: a resource for studying parasite biology. Genome Research.
25. Blake DP et al. Eimeria tenella and Eimeria necatrix: genetic diversity and population structure. Infection, Genetics and Evolution.
26. Cantacessi C et al. The transcriptome of Eimeria tenella: insights into parasite biology. PLoS Neglected Tropical Diseases.
27. Schwartz RS et al. ITS1 sequencing for species identification of Eimeria. Journal of Parasitology.
28. Bilic I et al. Comparative evaluation of ITS1 and COI for Eimeria species discrimination. Parasitology Research.
29. Kvíčerová J et al. Phylogenetic relationships among Eimeria species from galliform birds. Folia Parasitologica.
30. Vrba V, Pakandl M. Molecular characterization of Eimeria tenella isolates from Czech farms. Veterinary Parasitology.
31. Haberkorn A. Chemotherapy of coccidiosis: mode of action and resistance. Proceedings of the World Veterinary Congress.
32. Morley AJ, Shimmield JW. The effects of salinomycin on oocyst production. Avian Pathology.
33. Challey JR, Jeffers TK. Anticoccidial activity of narasin. Journal of Parasitology.
34. McDougald LR. Drug resistance in Eimeria: a review. In: Coccidiosis of Poultry.
35. Ryley JF et al. Toltrazuril: a new anticoccidial agent. Veterinary Record.
36. Gresham ACJ et al. Efficacy of diclazuril against field isolates. Avian Pathology.
37. Jordan FTW. Amprolium resistance in Eimeria tenella. British Veterinary Journal.
38. Joyner LP. The response of drug-resistant strains of Eimeria to combinations of anticoccidials. Parasitology.
39. Long PL. The use of shuttle programs for coccidiosis control. Avian Diseases.
40. Conway DP et al. In-feed anticoccidial combinations: field evaluation. Avian Pathology.
41. Chapman HD et al. A survey of anticoccidial sensitivity in broilers. Veterinary Parasitology.
42. Peek HW et al. Resistance to anticoccidials in Dutch broilers. Tijdschrift voor Diergeneeskunde.
43. Xu P et al. Artemisinin derivatives inhibit Eimeria tenella in vitro. Veterinary Parasitology.
44. Bafundo KW. The use of saponins as immunomodulators in poultry. Poultry Science.
45. Kouakou B et al. Tannin-rich feed additives and coccidiosis. Journal of Animal Science.
46. Ricke SC. Prebiotics and organic acids for poultry gut health. World's Poultry Science Journal.
47. Sklan D et al. Butyric acid enhances performance during coccidiosis. Poultry Science.
48. Branton SL et al. In ovo vaccination against coccidiosis: feasibility study. Avian Diseases.
49. Dardi M et al. Recombinant EtMIC2 vaccine efficacy in broilers. Vaccine.
50. Jenkins MC et al. Gamma-irradiated oocyst vaccines for coccidiosis. Avian Diseases.